Knee Replacements by Dr Ashok Rajgopal ramp up to 40,000 Mark & Counting

Globally acclaimed Orthopaedic Surgeon @Medanta ‘felt weak in the knees’ among doting patients

Gurugram/ New Delhi: 40,000 knee replacement surgeries by a single doctor is simply an astronomical number which none other than globally acclaimed orthopedic surgeon at Medanta-the Medcity, Dr Ashok Rajgopal has reached to become a cut above the rest in the domain.

The top notch surgeon has the distinction of doing 31 knee replacements in a day. Going by this rate, 50,000 mark too is not far away. The fact is no other orthopedic surgeon in India is anywhere near this number. No one seems to be in race to ace him. In an event organized to mark this milestone, his patients, young and old, had turned out in great numbers. Many of them narrated how flawless knee replacement surgeries transformed their lives. Dr Rajgopal ramp walked with many of his patients. They shared their respective journeys – from one of pain and vulnerability, to a life of liberty and empowerment, free from any discomfort. Dr Rajgopal felt emotionally overwhelmed.

Dr. Ashok Rajgopal, Group Chairman – Medanta Institute of Musculoskeletal Disorders and Orthopaedics, undoubtedly enforced Brand’s leadership in Orthopaedic Excellence. The landmark feat is a testament to Dr. Rajgopal’s pioneering skills and decades-long experience, as well as Medanta’s commitment to advancing joint replacement care in India by using advanced infrastructure, state-of-the-art technology, and a skilled team of doctors, at an accessible cost.

Dr Naresh Trehan, Chairman and Managing Director, Medanta, congratulated Dr Rajgopal and his team for watershed achievement. Mr Pankaj Sahni, Group CEO, Medanta, also lauded his enviable accomplishments.

On this occasion Dr Rajgopal said, “Orthopaedic care in India, particularly knee replacement, has advanced tremendously over the past few years. Today, more than 2.5 lakh knee replacements are performed annually — nearly 2.5 times more than just five years ago.2 This sharp rise is being driven by increased longevity, greater awareness, the aspiration to stay active, and the availability of advanced expertise and infrastructure. With advanced surgical techniques and patient-specific approaches, we are able to restore mobility, independence, and quality of life for thousands. At the same time, challenges such as revision surgeries and complications demand careful evaluation and long-term patient care. In our unit, we are equipped to manage even the most complex cases with cutting-edge technology and clinical expertise.”

Dr Rajgopal further said,“We treat thousands of patients with advanced knee conditions every year and perform approximately 1600-1700 knee replacements annually, achieving a 98% success rate. We have successfully managed more than 9500 revision surgeries and performed over 1500 robotic-assisted knee replacements. Our focus goes beyond surgical excellence—we emphasize pre-operative assessment, patient education, and structured rehabilitation, which are key to longterm success. With innovations like robotics, minimally invasive techniques, and advanced implants, we are able to personalize treatment, reduce recovery time, and deliver superior outcomes. We remain committed to improving lives through a blend of expertise, compassion, and comprehensive care.”

Related Posts

Will ‘Epidemic’ of Bridge Collapse in Bihar halt with new Minister in?

Hope floats for good ‘Health’ of Bridges, Flyovers & Roads in the state Patna/ New Delhi: Talking of bridges, roads and flyovers in terms of ‘health’ may sound a bit…

Patient dies after oxygen supply stops in ambulance

Family stages protest outside hospital mortuary, demands action A 20-year-old patient referred from Pali to Jodhpur died in an ambulance after the oxygen supply reportedly stopped midway. Following the incident,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

Piramal Pharma Gets 3 USFDA Observations at US Facility

Piramal Pharma Gets 3 USFDA Observations at US Facility

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices